Contraception
Volume 81, Issue 4 , Pages 309-315 , April 2010

Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women

  • Ana Cristina S. Rebelo

      Affiliations

    • Universidade Federal de São Carlos, 13565905 São Carlos-SP, Brazil
    • Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, 13400911 Piracicaba-SP, Brazil
    • Corresponding Author InformationCorresponding author. Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, Rodovia do Açúcar, km 156; 13400911 Piracicaba-SP, Brazil. Fax: +55 19 3124 1515x1558.
    • ,
  • Roberta S. Zuttin

      Affiliations

    • Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, 13400911 Piracicaba-SP, Brazil
    • ,
  • Rozangela Verlengia

      Affiliations

    • Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, 13400911 Piracicaba-SP, Brazil
    • ,
  • Marcelo de C. Cesar

      Affiliations

    • Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, 13400911 Piracicaba-SP, Brazil
    • ,
  • Marcos Felipe Silva de Sá

      Affiliations

    • Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Ginecologia e Obstetrícia, 14048900 Riberão Preto-SP, Brazil
    • ,
  • Ester da Silva

      Affiliations

    • Universidade Federal de São Carlos, 13565905 São Carlos-SP, Brazil
    • Universidade Metodista de Piracicaba, Faculdade de Ciências da Saúde, 13400911 Piracicaba-SP, Brazil

Received 6 October 2009 ,Revised 3 November 2009 ,Accepted 9 November 2009.

References 

  1. Perrotti M, Bahamondes L, Petta C, Castro S. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate. Fertil Steril. 2001;76:469–473
  2. Shufelt CL, Petitti DB. Clinical practice. Combination estrogen–progestin oral contraceptives. N Engl J Med. 2003;349:1443–1450
  3. D'Eon TM, Sharoff C, Chipkin SR, Grow D, Ruby BC, Braun B. Regulation of exercise carbohydrate metabolism by estrogen and progesterone in women. Am J Physiol Endocrinol Metab. 2002;283:E1046–E1055
  4. Casazza GA, Jacobs KA, Suh SH, Miller BF, Horning MA, Brooks GA. Menstrual cycle phase and oral contraceptive effects on triglyceride mobilization during exercise. J Appl Physiol. 2004;97:302–309
  5. Notelovitz M, Zauner C, McKenzie L, et al. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report. Am J Obstet Gynecol. 1987;156:591–598
  6. Giacomoni M, Falgairette G. Decreased submaximal oxygen uptake during short duration oral contraceptive use: a randomized cross-over trial in premenopausal women. Ergonomic. 2000;43:1559–1570
  7. Casazza GA, Miller SBF, Navazio FM, Brooks GA. Effects of oral contraceptives on peak exercise capacity. Appl Physiol. 2002;93:1698–1702
  8. Lebrun CM, Petit AM, McKenzie DC, Taunton JE, Prior JC. Decreased maximal aerobic capacity with use of a triphasic oral contraceptive in highly active women: a randomized controlled trial. Br J Sports Med. 2003;37:315–320
  9. Bonen A, Haynes FW, Graham TE. Substrate and hormonal responses to exercise in women using oral contraceptives. J Appl Physiol. 1991;70:1917–1927
  10. Santos MCS, Rebelo ACS, Zuttin RS, César MC, Catai AM, Silva E. Influence of oral contraceptive use on lipid levels and cardiorespiratory responses among healthy sedentary women. Braz J Phys Ther. 2008;12:188–194
  11. Bryner RW, Toffle RC, Ullrich IH, et al. Effect of low dose oral contraceptives on exercise performance. Br J Sports Med. 1996;30:36–40
  12. Lynch NJ, De Vito G, Nimmo MA. Low dosage monophasic oral contraceptive use and intermittent exercise performance and metabolism in humans. Eur J Appl Physiol. 2001;84:296–301
  13. Rickenlund A, Carlström K, Ekblom B, et al. Effects of oral contraceptives on body composition and physical performance in female athletes. J Clin Endocrinol Metab. 2004;89:4364–4370
  14. Beaves WL, Wasserman K, Whipp BJ. A new method for detecting the anaerobic threshold by gas exchange. J Appl Physiol. 1986;60:2020–2027
  15. Wasserman K, Hansen JE, Sue D, et al. Principles of exercise testing and interpretation. Philadelphia (Pa): Williams & Wilkins; 1999;
  16. Higa MN, Silva E, Neves VF, Catai AM, Gallo L, Silva de Sá MF. Comparison of anaerobic threshold determined by visual and mathematical methods in healthy women. Braz J Med Biol Res. 2007;40:501–508
  17. Redman LM, Scroop GC, Westlander G, Norman RJ. Effect of a synthetic progestin on the exercise status of sedentary young women. J Clin Endocrinol Metab. 2005;90:3830–3837
  18. Stang A, Schwingl B, Rivera R. New contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community-based programmes. WHO. 2000;78:1015–1023
  19. Silva E, Catai AM, Trevelin LC, et al. Design of a computerized system to evaluate the cardiac function during dynamic exercise. [abstract] Phys Med Biol. 1994;33:P409
  20. Crescêncio JC, Martins LE, Murta LO, et al. Measurement of anaerobic threshold during dynamic exercise in healthy subjects: comparison among visual analysis and mathematical models. Comput Cardiol. 2003;30:801–804
  21. O'Brien PA. The third generation oral contraceptive controversy. The evidence shows they are less safe than second generation pills. BMJ. 1999;319:795–796
  22. Nofer JR, Kehrel B, Fobker M, et al. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 2002;161:1–16
  23. Gaspard U, Endrikat JP, Desager C, et al. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles. Contraception. 2004;69:271–278
  24. Rechichi C, Dawson B, Goodman C. Oral contraceptive phase has no effect on endurance test. Int J Sports Med. 2008;29:277–281
  25. Cagnacci A, Ferrari S, Tirelli A, Zanin R, Volpe A. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial. Contraception. 2009;79:111–116
  26. Krauss RM, Burkman RT. The metabolic impact of oral contraceptives. Am J Obstet Gynecol. 1992;167:1177–1184
  27. Wright KP, Johnson JV. Evaluation of extended and continuous use oral contraceptives. Ther Clin Risk Manag. 2008;4:905–911
  28. Winkler UH, Sudik R. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters. Contraception. 2009;79:15–23
  29. Kenny GP, Leclair E, Sigal RJ, et al. Menstrual cycle and oral contraceptive use do not modify postexercise heat loss responses. J Appl Physiol. 2008;105:1156–1165
  30. Bushman B, Masterson G, Nelsen J. Anaerobic power performance and the menstrual cycle: eumenorrheic and oral contraceptive users. J Sports Med Phys Fitness. 2006;46:132–137
  31. Daggett A, Davies B, Boobis L. Physiological and biochemical responses to exercise following oral contraceptive use. [abstract] Med Sci Sports Exerc. 1983;15:174

☆ This research was supported by CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico, Process no. 370448/2007-3) and FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo, Process no. 2006/56788-1).

PII: S0010-7824(09)00489-2

doi: 10.1016/j.contraception.2009.11.005

Contraception
Volume 81, Issue 4 , Pages 309-315 , April 2010

Article Tools

* Image Usage & Resolution